Allogeneic blood-based therapies: hype or hope?
Eye (Lond)
.
2017 Apr;31(4):509-510.
doi: 10.1038/eye.2016.268.
Epub 2016 Dec 2.
Authors
E Anitua
1
2
,
M de la Fuente
2
,
J Merayo-Lloves
3
,
F Muruzabal
2
,
G Orive
1
2
4
5
Affiliations
1
Eduardo Anitua Foundation for Biomedical Research, Vitoria, Spain.
2
Research and Development, BTI - Biotechnology Institute, Vitoria, Spain.
3
Instituto Universitario Fernández-Vega, Universidad de Oviedo, Oviedo, Spain.
4
Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, Vitoria, Spain.
5
Networking Biomedical Research Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN, SLFPB-EHU, Vitoria, Spain.
PMID:
27911449
PMCID:
PMC5395995
DOI:
10.1038/eye.2016.268
No abstract available
MeSH terms
Blood Platelets* / chemistry
Eye Diseases / drug therapy*
Humans
Ophthalmic Solutions*
Plasma* / chemistry
Transplantation, Homologous
Substances
Ophthalmic Solutions